News
December 20, 2024
Phapros (PEHA) Distributes Rp 3.980 Billion MSE Funding Program in 2024
Phapros once again distributed the Micro and Small Enterprise (MSE) Funding Program Phase IV/2024...
See MoreNovember 22, 2024
Cervical Cancer Screening with HPV DNA Testing
HPV DNA screening is an examination to detect high-risk type Human Papillomavirus (HPV) virus infections in women. It involves taking a sample of cells from the cervix for laboratory examina...
See MoreOctober 31, 2024
Phapros wins Best BUMN Awards 2024 award
Phapros won the Best BUMN Awards 2024 for Encouraging Organizational Adaptability to Maintain Sustainable Growth in the Subsidiary/Healthcare category...
See MoreOctober 31, 2024
Phapros Initiates Audience and Collaboration with Semarang City DLH to Alleviate Environmental Issues
PT Phapros Tbk representatives from the EHS department and TJSL department conducted an audience and benchmarking directly to the Semarang City DLH on October 31, 2024....
See MoreOctober 30, 2024
Phapros receives Siddhakarya award
PT Phapros Tbk received the Siddhakarya award from the Central Java Provincial Government. ...
See MoreOctober 30, 2024
Towards Digital Transformation: Implementation of Industry 4.0 by PT Phapros Tbk
The INDI 4.0 score provides a comprehensive picture of PT Phapros Tbk's readiness to transform into the digital era....
See More